The global radiosurgery market size was valued at USD 2.62 billion in 2025 and is projected to grow from USD 2.79 billion in 2026 to USD 4.58 billion by 2034, registering a CAGR of 6.4% during the forecast period from 2026 to 2034. North America dominated the radiosurgery market with a market share of 39.8% in 2025.
In recent years, there has been an increase in the cases of cancer and neurological disorders, which is anticipated to drive the global radiosurgery market growth, as it is a non-invasive or minimally invasive treatment option that can help to treat these diseases. A surge in the geriatric population, which is prone to these diseases, is further estimated to augment the market expansion. Moreover, technological advancements in the radiosurgery field that enhance this procedure's efficacy are expected to create opportunities for global market growth.
Radiosurgery is a non-invasive medical procedure that uses precisely targeted radiation to treat tumors and other abnormalities in the body. Unlike traditional surgery, radiosurgery does not involve making incisions. Instead, it delivers highly focused radiation beams to the affected area, destroying abnormal tissue while minimizing damage to surrounding healthy tissue. This technique is commonly used to treat brain tumors, arteriovenous malformations (AVMs), trigeminal neuralgia, and other conditions.
Radiosurgery can be delivered through technologies such as Gamma Knife, CyberKnife, or linear accelerators. It offers several advantages, including shorter treatment times, lowered risk of complications, and the ability to treat tumors in delicate or inaccessible locations. Radiosurgery is often preferred for patients who are not suitable candidates for conventional surgery or those seeking a less invasive treatment option.
Download a Free Sample To learn more about this report,
AI-Assisted Treatment Planning Is Improving Radiosurgery Precision
The need for more accurate target identification and individualized treatment is increasing the use of AI in radiosurgery planning and outcome prediction. A 2026 systematic review of 21 studies found that AI models for brain metastases treated with stereotactic radiosurgery reported AUCs ranging from 0.70 to 0.98, with stronger results from models combining MRI-derived radiomics and clinical data. This transition can improve treatment planning, support risk stratification, and help clinicians identify patients who may require closer post-treatment monitoring.
MRI-Guided Radiosurgery Is Enabling Real-Time Treatment Adaptation
The need to account for anatomical changes during multi-session treatment is increasing interest in MRI-guided radiosurgery and online adaptive workflows. A 2025 study of 26 intracranial cases demonstrated the feasibility of online adaptive fractionated stereotactic radiosurgery using a low-field MR-linear accelerator, with simulated end-to-end validation showing a less than 2.5% difference between measured and planned target dose. This shift can improve target coverage and normal-brain sparing while allowing treatment plans to respond more precisely to changes during therapy.
Cancer Center Expansion and Rising Brain and Spinal Tumor Cases Increase Radiosurgery Demand and Drive Market Growth.
Expansion of cancer treatment centers increases demand for advanced radiation equipment as hospitals add capacity for specialized oncology services. Greater availability of radiotherapy infrastructure creates additional requirements for radiosurgery systems, treatment platforms, and supporting equipment. The outcome is higher procurement demand from hospitals and oncology centers seeking to expand treatment capacity. For example, national cancer programs such as Tanzania’s expansion of cancer centers have included increased access to radiotherapy services and related oncology infrastructure.
The burden of brain and central nervous system tumors creates continued demand for treatment options that can address tumors in sensitive anatomical locations. This patient need supports the use of radiosurgery systems for selected brain and spinal tumors where highly focused radiation can be clinically appropriate. The outcome is greater demand for specialized radiosurgery equipment and treatment services at oncology facilities. IARC reported 321,731 new brain and CNS cancer cases globally in 2022, illustrating the patient population requiring specialized cancer care.
High Cost of Radiosurgery Systems and Treatment and Limited Access to Advanced Radiosurgery Facilities Restrain Market Expansion
High costs of radiosurgery systems and treatment can limit adoption among hospitals and patients, particularly where healthcare budgets are constrained. Advanced equipment, installation, maintenance, treatment planning, and specialized clinical services increase the overall cost of radiosurgery. These financial barriers can delay equipment purchases, restrict patient access, and slow market expansion.
Limited access to advanced radiosurgery facilities can restrict the availability of specialized treatment, particularly in rural and underserved regions. High infrastructure requirements, limited treatment centers, and uneven distribution of advanced equipment can make patients dependent on distant specialized hospitals. These access gaps can reduce procedure volumes and limit the broader adoption of radiosurgery
Radiosurgery-Immunotherapy Integration and Outpatient Services Are Creating New Revenue Opportunities and Offers Growth Market Opportunities.
Oncology hospitals, cancer centers, radiation specialists, and pharmaceutical companies can combine radiosurgery with immunotherapy for selected cancer treatment pathways. Combination protocols create revenue opportunities through treatment packages, clinical collaborations, and demand for advanced radiation systems. Companies such as Varian and Elekta operate in advanced radiation oncology technologies.
Hospitals, ambulatory treatment centers, and radiation oncology providers can deliver selected radiosurgery procedures without prolonged inpatient stays. Outpatient models create revenue through higher treatment throughput, facility utilization, procedure-based payments, and related patient services. Companies such as Accuray provide radiosurgery systems that support outpatient treatment settings.
Shortage of Specialized Radiosurgery Professionals and Complex Treatment Planning for Multiple Tumors Hinder Market Growth.
Radiosurgery requires radiation oncologists, medical physicists, dosimetrists, and trained technologists with specialized expertise. Workforce shortages and uneven distribution can limit treatment capacity, increase operational pressure, and make it difficult for providers to expand services. WHO continues to report persistent global health-workforce shortages and distribution gaps.
Accurate radiosurgery planning becomes more difficult when patients have multiple lesions, large tumors, or rapidly changing tumor volumes. These cases require repeated imaging, careful dose optimization, and multidisciplinary decisions, increasing workflow complexity and limiting the number of patients that centers can efficiently treat.
The electron emitting high-energy linear accelerator (linac) segment, dominated the market with a market share of 48.7% in 2025. Linear accelerators generate high-energy radiation beams that can be precisely directed toward targeted areas, making them widely used in modern radiation treatment. The cobalt 60 systems (gamma knife) segment, and proton beam therapy segment, also support precise radiation-based treatment for different clinical applications.
The proton beam therapy segment, is expected to grow at the fastest CAGR of 6.8% during the forecast period 2026–2034. Proton beam therapy uses protons to deliver radiation to targeted tissues, with treatment planning focused on controlling the dose delivered to the treatment area. The electron emitting high-energy linear accelerator (linac) segment, and cobalt 60 systems (gamma knife) segment, continue to be used for specialized radiation treatment procedures.
Request Customizationto receive a tailored report.
The hospitals segment, dominated the market with a market share of 68.9% in 2025 and is also expected to grow at the fastest CAGR of 6% during the forecast period 2026–2034. Hospitals commonly provide advanced diagnostic and radiation treatment facilities and can support multidisciplinary cancer care involving radiation oncologists, medical physicists, and other healthcare professionals.
The clinics segment, and others segment also contribute to the use of radiosurgery technologies. Clinics can provide specialized treatment services, while other healthcare facilities may use radiosurgery systems based on their available infrastructure and clinical requirements.
Speak to an Analystto discuss market opportunities.
North America radiosurgery market held the dominant position, accounting for a 39.8% share in 2025. The region benefits from advanced healthcare infrastructure, high adoption of advanced surgical technologies, and increasing demand for minimally invasive treatment options. U.S. radiosurgery market is supported by an aging population, with the U.S. Census Bureau projecting the share of people aged 65 and older to increase from 18.9% in 2025 to 23.4% by 2060, increasing the potential need for advanced treatment and surgical technologies.
Canada radiosurgery market is expected to benefit from demographic aging, with Statistics Canada projecting the population aged 65 and older to increase from 19.5% in 2025 to between 22.6% and 32.5% by 2075, supporting greater demand for specialized healthcare services.
Unlock Regional Insightsto access country-level data, & regional trends.
Europe radiosurgery market is projected to register the fastest CAGR of 6.6% during the forecast period, supported by expanding access to advanced medical technologies, established healthcare systems, and growing adoption of precision-based treatment approaches. U.K. radiosurgery market is likely to see increasing demand for advanced treatment technologies as the Office for National Statistics projects people aged 65 and older to account for 23.6% of the population by 2035, up from 20.2% in 2025.
Germany radiosurgery market is supported by continued population aging, with the Federal Statistical Office projecting that one in four people will be aged 67 or older by 2035, compared with one in five in 2024, increasing the need for advanced healthcare services. France radiosurgery market is expected to benefit from demographic aging, with INSEE projecting 49 people aged 65 or older for every 100 people aged 20–64 by 2040, compared with 40 per 100 in 2026, supporting demand for specialized medical care.
Asia Pacific radiosurgery market accounted for a 22.1% share in 2025 and is projected to grow at a CAGR of 6.3%, driven by improving healthcare infrastructure, rising awareness of advanced treatment options, and increasing adoption of image-guided and minimally invasive procedures. Japan radiosurgery market is likely to see sustained demand for advanced treatment solutions as Japan’s Ministry of Health, Labour and Welfare projects people aged 65 and older to account for approximately 35% of the population by 2040.
China radiosurgery market is supported by rapid demographic aging, with the Chinese government reporting that the population aged 60 and older reached 323.38 million in 2025 and is projected to exceed 400 million by around 2035, increasing healthcare requirements for older adults. India radiosurgery market is supported by a rapidly expanding elderly population, with UNFPA projecting that 346 million Indians, or nearly 21% of the population, will be aged over 60 by 2050, increasing the potential need for specialized healthcare and advanced treatment technologies.
The Radiosurgery Market is moderately concentrated, with competition comprising radiation therapy equipment manufacturers, specialized radiosurgery companies, treatment-planning software providers, medical imaging companies, and precision oncology technology firms. The leading players in the Radiosurgery Market are Siemens Healthineers, Varian Medical Systems, Elekta AB, Accuray Incorporated, and Ion Beam Applications SA; a reliable cumulative market-share percentage specifically for these five companies is not publicly disclosed, so no unsupported figure is assigned to their combined global market share.
Established players compete through clinical evidence, treatment precision, installed equipment bases, technology portfolios, regulatory approvals, service networks, and integration of imaging, planning, and treatment delivery systems. Emerging players in the radiosurgery market ecosystem compete through specialized platforms, AI-enabled treatment planning, advanced motion management, compact systems, flexible workflows, and cost-efficient solutions. Competitive differentiation also depends on treatment speed, accuracy, workflow automation, interoperability, patient positioning, and the ability to support different tumor sites and clinical applications.
Customize This Report to Match Your Strategic Objectives
Author's Details
Senior Research Associate
Dhanshee Bhapkar is a healthcare research professional with 4+ years of experience in market intelligence, specializing in market analysis, secondary research, market estimation, and forecasting across the pharmaceutical, biopharmaceutical, and medical device sectors. She provides actionable insights into market dynamics, competitive intelligence, industry trends, and growth opportunities to support strategic business decision-making.
Her expertise includes assessing market size, growth potential, and revenue opportunities through structured market estimation and forecasting methodologies, including top-down, bottom-up, and epidemiology (EPI)-based approaches. She has hands-on experience analyzing disease epidemiology, treatment landscapes, market trends, competitive scenarios, and industry developments to develop robust market forecasts.
Interventional Cardiology Devices Market Size, Share, Growth, 2034
Smart Inhalers Market Size, Share, Growth, Analysis, Report, 2034
Irradiation Apparatus Market Size, Share, Growth, Analysis, 2034
ECG Patch and Holter Monitor Market Size, Share, Growth, 2034
Dermatology Excimer Laser Market Size, Share, Growth, Analysis, 2034
Disposable Medical Gloves Market Size, Share, Growth, Analysis, 2034
We are featured on:
sales@straitsresearch.com